Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Foreseeing the Moments of Occurrence of Everolimus Long-term Side Effects by Follow up of Trough Blood Concentrations

NCT03033186 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.

NCT NCT03033186
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03033186 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Foreseeing the Moments of Occurrence of Everolimus Long-term Side Effects by Follow up of Trough Blood Concentrations
Lead sponsor
Maastricht University Medical Center
Phase
Observational
Overall status
Unknown status
Start date
May 16, 2017
Completion date
December 31, 2018
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, gastrointestinal neuroendocrine tumour, neuroendocrine neoplasm of lung, pancreatic neuroendocrine tumour, renal cell carcinoma